sameAs
Inhibition of Akt/mTOR signaling by the dietary flavonoid fisetinUpdates of mTOR inhibitorsThe use of lentinan for treating gastric cancerNatural products as aromatase inhibitorsTumor-derived extracellular fragments of receptor protein tyrosine phosphatases (RPTPs) as cancer molecular diagnostic toolsTumor initiation in human malignant melanoma and potential cancer therapiesAre KRAS/BRAF mutations potent prognostic and/or predictive biomarkers in colorectal cancers?β2-Microglobulin-mediated signaling as a target for cancer therapyAdenoviral vectors for prodrug activation-based gene therapy for cancerCancer prevention with promising natural products: mechanisms of action and molecular targetsRole of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesisCancer nanotechnology: emerging role of gold nanoconjugatesPrevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptorSmac/DIABLO and colon cancerHepatocellular carcinoma detection by gallium scan and subsequent treatment by gallium maltolate: rationale and case studyCytotoxic and antitumor potentialities of aporphinoid alkaloidsThe intermediate enzymes of isoprenoid metabolism as anticancer targetsChk1 inhibitors for novel cancer treatmentProspects for hypoxia-activated anticancer drugsPlants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggabilityCholesterol, cardiolipin, and mitochondria permeabilisationCell cycle control by the CDC25 phosphatasesCDC25A: a rebel within the CDC25 phosphatases family?The role of Cdc25A in the regulation of cell proliferation and apoptosisSuperoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxideGlucose-6-phosphate dehydrogenase: a biomarker and potential therapeutic target for cancerChemical metabolic inhibitors for the treatment of blood-borne cancersBlood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative DiseasesEvolving Therapies and FAK Inhibitors for the Treatment of CancerCamptothecins and Topoisomerase I; A Foot in the Door. Targeting the Genome Beyond Topoisomerase I with Camptothecins and Novel Anticancer Drugs; Importance of DNA Replication, Repair and Cell Cycle CheckpointsIn vitro anticancer evaluation of platinum(II/IV) complexes with diisoamyl ester of (S,S)-ethylenediamine-N,N'-di-2-propanoic acid.Lenalidomide in an in vitro Dendritic Cell Model for Malignant Gliomas.Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes.Recent advances in the development of P-gp inhibitors.Curcumin-based anti-prostate cancer agents.An orally bioavailable c-Met kinase inhibitor potently inhibits brain tumor malignancy and growth.Camptothecin: roles of the D and E rings in binding to the topoisomerase I-DNA covalent binary complex.Antioxidant activity and chemical components as potential anticancer agents in the olive leaf (Olea europaea L. cv Leccino.) decoction.Unusual DNA conformations: implications for telomeres.Design of new anti-cancer agents based on topoisomerase poisons targeted to specific DNA sequences.
P1433
Q24568189-EB2406EF-7B91-4719-AFA3-5DF004C0D759Q24607170-0E376744-EE05-417F-A5B8-59F3F3E5DE20Q24619416-43AC14D9-1F66-4F73-8619-35290E3A6E96Q24620153-08986968-98FB-4B60-934D-E0EC78359BC5Q24632950-9DC04DF7-48F0-4C74-A771-26BA468EDEF4Q24634207-0F997B94-E582-4E15-A16F-C79CB1005759Q26828992-2F403C0E-0E7E-4329-BCAE-51E4312E64B2Q26853735-E78D3AEA-EE6A-481E-B1C9-67EDCEFF2FDEQ26860729-F5C3CFA6-936E-4019-B68D-855474AC5072Q27006530-00348132-6EE1-4B1B-9D97-E21F1C8BFBDAQ27011538-E1BEA6FA-0D51-4016-A8A4-791F4919E825Q27021820-FD0B0410-D8AD-4D57-B4BE-86FC6D4737A1Q27022976-8F24C182-4834-466D-89C1-057B43EB68E2Q28236572-1A06228E-8A5B-4CA1-9798-083543BED0C2Q28237090-BF2874A5-2F06-4A05-B9E1-F1A096B45716Q28240517-E4D84D32-CA62-4D2D-9EDE-2CCB0DF3B3EBQ28248209-507F9A15-B41D-422F-B748-8BDDF47986AEQ28252085-DA9E528A-A53D-4981-A483-397383AA94FAQ28283178-1653C858-66FF-4222-A8D2-51CDB3257A83Q28385642-2AFAE2AA-C63D-436A-B2A7-AE3EEED36B72Q28609479-BA5BA32B-E6A4-4DC6-BE9E-88D6247E9710Q28611403-66484D33-BF00-4464-83B8-02621D9038A2Q28611404-4679F3C0-C018-4A49-B2B2-2BFBD7BFF68EQ28611420-202E40B5-CFC4-4429-9F97-B3B759D8B138Q28647012-99D22CFF-28B7-448D-8F66-C3F3CC7F76E6Q28647040-703AA87E-B817-40EB-96A6-655492143EA4Q28822335-D6B202A8-78FF-44A5-8DC8-3C6E0640DFC8Q28829017-FA966C3D-CFC8-4741-9F10-75548BFEA1E9Q28972291-E87C1C74-7A5F-4DDA-8709-38B6E2AACC96Q29308218-4C9F6EAF-DC19-41B6-9C3E-25693DF30D49Q30313647-9132446F-D89D-4127-BC7D-6356CF316A27Q30315553-94000A67-4E68-4DFD-8589-1E30DD3A0678Q30316001-17703BB1-F8A1-4570-9600-5EB68313D113Q30319108-E07010FA-4C39-47B3-9A7B-994411C89E6BQ30370850-3802D439-9A29-433A-8BDA-D4D029AE5F29Q30428363-2553D07A-A9E6-47B7-8A5F-48E516C602DFQ30437790-8F9C24B2-1683-48F3-BD10-07923C681945Q30841220-E8275B47-B9BF-4C36-96E7-E7BE74463EDFQ30912281-36DFB2CB-BF8D-4594-ADC1-8D3E8EEF0874Q30912286-9FA6C2AC-3851-43E2-B613-614DB455CCA3
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Bentham Science Publishers
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
Anti-Cancer Agents in Medicinal Chemistry
@ast
Anti-Cancer Agents in Medicinal Chemistry
@da
Anti-Cancer Agents in Medicinal Chemistry
@de
Anti-Cancer Agents in Medicinal Chemistry
@en
Anti-Cancer Agents in Medicinal Chemistry
@es
Anti-Cancer Agents in Medicinal Chemistry
@fi
Anti-Cancer Agents in Medicinal Chemistry
@fr
Anti-Cancer Agents in Medicinal Chemistry
@it
Anti-Cancer Agents in Medicinal Chemistry
@nb
Anti-Cancer Agents in Medicinal Chemistry
@nl
type
label
Anti-Cancer Agents in Medicinal Chemistry
@ast
Anti-Cancer Agents in Medicinal Chemistry
@da
Anti-Cancer Agents in Medicinal Chemistry
@de
Anti-Cancer Agents in Medicinal Chemistry
@en
Anti-Cancer Agents in Medicinal Chemistry
@es
Anti-Cancer Agents in Medicinal Chemistry
@fi
Anti-Cancer Agents in Medicinal Chemistry
@fr
Anti-Cancer Agents in Medicinal Chemistry
@it
Anti-Cancer Agents in Medicinal Chemistry
@nb
Anti-Cancer Agents in Medicinal Chemistry
@nl
prefLabel
Anti-Cancer Agents in Medicinal Chemistry
@ast
Anti-Cancer Agents in Medicinal Chemistry
@da
Anti-Cancer Agents in Medicinal Chemistry
@de
Anti-Cancer Agents in Medicinal Chemistry
@en
Anti-Cancer Agents in Medicinal Chemistry
@es
Anti-Cancer Agents in Medicinal Chemistry
@fi
Anti-Cancer Agents in Medicinal Chemistry
@fr
Anti-Cancer Agents in Medicinal Chemistry
@it
Anti-Cancer Agents in Medicinal Chemistry
@nb
Anti-Cancer Agents in Medicinal Chemistry
@nl
P236
P6981
P1055
P1058
P1156
P1277
P1476
Anti-Cancer Agents in Medicinal Chemistry
@en
P236
P407
P571
2001-01-01T00:00:00Z